Product Species
    See more See less
    Product Targets
    Product Marks
    See more See less
    Product Size
    See more See less

    TNFRSF11B Overview

    Osteoprotectin (OPG), also known as osteoclast inhibitory factor (OCIF) or tumor necrosis factor receptor superfamily member 11B(TNFRSF11B), is a cytokine receptor that is a member of the tumor necrosis factor receptor superfamily. OPG reduces the production of osteoclasts by inhibiting the differentiation of osteoclast precursors into osteoclasts, and also regulates the absorption of osteoclasts in vitro and in vivo. Recombinant human OPG acts specifically on bone and can increase bone mineral density and volume. Elevated OPG levels have been reported in patients with heart disease and severe mental disorders. In recent years, researchers have speculated that OPG may have a link between bone and cardiovascular disease, specifically associated with increased cardiovascular risk in people with diabetes.

    TNFRSF11B Molecular Product List